Skip to main content

Table 2 Classification of patients with ASMD

From: Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

 

Infantile neurovisceral (ASMD type A)

Chronic neurovisceral (intermediate ASMD, ASMD A/B, variant ASMD B)

Chronic visceral (ASMD type B)

Phenotype

Infantile onset of severe visceral involvement and neurodegeneration with progressive psychomotor deterioration

Visceral features of NPD B as well as neurologic findings including ataxia, variable degrees of developmental delay and peripheral neuropathy

Chronic progressive multi-system or oligosymptomatic, stable disease with no or little neurologic involvement

Natural History

Relentless progression of neurologic and visceral disease and death typically by 3 years of age

Wide spectrum of disease manifestations and severity, with slow progression Patients live past early childhood and sometimes into adulthood

Wide spectrum of disease manifestations and severity. Sometimes oligosymptomatic. Survival usually extends well into adulthood and may even be normal. Patient may remain stable for years